No abstract available
Keywords:
32 Biomedical and Clinical Sciences
,3212 Ophthalmology and Optometry
,Neurosciences
,Eye Disease and Disorders of Vision
,Macular Degeneration
,Neurodegenerative
,Eye
,Aged
,Aged, 80 and over
,Angiogenesis Inhibitors
,Antibodies, Monoclonal, Humanized
,England
,Female
,Humans
,Intravitreal Injections
,Macular Degeneration
,Male
,Middle Aged
,Outcome Assessment, Health Care
,Prospective Studies
,Ranibizumab
,Visual Acuity
